With its stock down 5.6% over the past three months, it is easy to disregard NIOX Group (LON:NIOX). However, stock prices are usually driven by a company’s financial performance over the long ...

With its stock down 5.6% over the past three months, it is easy to disregard NIOX Group (LON:NIOX). However, stock prices are usually driven by a company’s financial performance over the long term, ...

Oxford, UK - 16 January 2025: NIOX Group plc ("NIOX", the "Company" or the "Group"; AIM: NIOX), a medical device company focused on point of care asthma diagnosis, monitoring and management ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Operating profit is forecast to rise to GBP8.4 million from GBP8.0 million. Niox Group PLC - Oxford-based developer of medical devices for asthma diagnosis and management - Expects revenue of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

“Our manufacturing partner continues to work on the development of the next generation Niox Pro device which is expected to be launched towards the end of 2025.” Johnson said that during ...